Botulinum Toxin for Carpal Tunnel Syndrome

Withdrawn before enrolling · Phase 2

Conditions studied: Carpal Tunnel Syndrome

In brief

To compare local steroid injections to local Botulinum toxin A injection in a double-blinded study.

Key facts

Study ID

NCT00701233

Run by

University of Minnesota

People needed

0

Starts

2012-06-01

Expected to finish

2018-10-01

Last updated by the study team

2019-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any individual with symptoms of carpal tunnel syndrome and a diagnosis of CTS either clinically or via EMG will be included into this study. There will be a total of 20 subjects displaying symptoms of CTS. The gender of the subjects will not determine enrollment. There is no requirement of male to female ratio for this study. There is no age cut-off or minimal age requirement to enroll in the study. No specific Racial or ethnic restrictions will be present for this study. Female subjects of childbearing potential (not surgically sterile or postmenopausal for at least 2 years) must have a negative pregnancy test at screening.

You may not qualify if…

• Any individual who has a diagnosis of CTS (by EMG or other means) but no symptoms of CTS will be excluded from this study.
• Vulnerable subjects as defined as children, pregnant women, those with limited autonomy, decisional incapacity and prisoners will not be enrolled in this study.
• Individuals with any history of carpal tunnel release surgery and recurrent or persistent symptoms will be excluded form this study.
• Subject is pregnant or lactating.

Where it is running

• University of Minnesota PM&R Department — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.